Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Questions remain about whether people with HIV are more at risk for severe COVID-19, as evidence to date is mixed.
A new simulation suggests that by 2030, multimorbidity in people with HIV will rise substantially.
But new data add to the evidence that mother-to-infant transmission of the coronavirus appears to be rare.
At one Ryan White clinic in Virginia, the likelihood of multiple health conditions increased over time.
New guidelines recommend focusing on healthy foods but don’t restrict added sugars or alcohol as much as some experts had hoped.
A recent study links diabetes to advanced liver damage in people with HIV.
High blood pressure, diabetes, lung disease and cardiovascular disease are all more prevalent among women with HIV.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
People living with diabetes are at a much greater risk of developing severe COVID-19 complications.
The diabetes drug was tied to a decline in body weight during a small study of people with HIV who didn’t have the condition.
These two integrase inhibitors are associated with high blood sugar and diabetes.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.